Exacerbation Rate Reduction With Mepolizumab Stratified by Maintenance Oral Corticosteroids Use and Eosinophil Levels: A Post Hoc Analysis of the DREAM and MENSA Studies
- PMID: 34085935
- DOI: 10.18176/jiaci.0714
Exacerbation Rate Reduction With Mepolizumab Stratified by Maintenance Oral Corticosteroids Use and Eosinophil Levels: A Post Hoc Analysis of the DREAM and MENSA Studies
Keywords: Asthma; Eosinophils; Exacerbations; Mepolizumab; Oral corticosteroids (OCS).
Comment on
-
Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma.Eur Respir J. 2018 Oct 18;52(4):1800936. doi: 10.1183/13993003.00936-2018. Print 2018 Oct. Eur Respir J. 2018. PMID: 30139780 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
